Clinical trial
A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic…
NCT00443651 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00443651 |
|---|---|
| Title | A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis |
| Official title | An Open-Label, Prospective Study of the Safety of Rituximab in Combination With Other Disease-Modifying Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis |
| Acronym | SUNDIAL |
| Lead sponsor | Genentech, Inc., Industry |
| Collaborators | Biogen Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Rituximab, Anti-inflammatory drugs |
| Enrollment | 578 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2011 |
| Completion | Feb 1, 2013 |
| First posted | Mar 6, 2007 |
| Last update posted | Apr 17, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: